“…anipamil, verapamil, calcium antagonist, ischemia, reperfusion, cardioprotection Roberto Ferrari, Riccardo Raddino, Claudio Ceconi, Salvatore Curello, Salvatore Ghielmi, Odoardo Visioli Cattedra di Cardiologia e Cattedra di Chimica, Universita degli Studi di Brescia, Brescia, Italy utilization and decreasing ATP production [2]. These considerations have stimulated, during the last few years, a growing interest in the possibility of reducing ischemic injury with agents commonly referred to as calcium antagonists [3][4][5].
…”